![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/428 | |
A61P 43/00 | |||
A61P 25/28 | |||
A61P 35/00 | |||
A61P 35/02 |
(11) | Number of the document | 3038467 |
(13) | Kind of document | T |
(96) | European patent application number | 14836513.3 |
Date of filing the European patent application | 2014-08-13 | |
(97) | Date of publication of the European application | 2016-07-06 |
(45) | Date of publication and mention of the grant of the patent | 2020-07-29 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2014/050943 |
Date | 2014-08-13 |
(87) | Number | WO 2015/023786 |
Date | 2015-02-19 |
(30) | Number | Date | Country code |
201361865592 P | 2013-08-13 | US | |
201461987117 P | 2014-05-01 | US |
(72) |
BOZIK, Michael E., US
DWORETZKY, Steven, US
|
(73) |
Knopp Biosciences LLC,
2100 Wharton Street, Suite 615, Pittsburgh, PA 15203,
US
|
(54) | COMPOSITIONS AND METHODS FOR TREATING PLASMA CELL DISORDERS AND B-CELL PROLYMPHOCYTIC DISORDERS |
COMPOSITIONS AND METHODS FOR TREATING PLASMA CELL DISORDERS AND B-CELL PROLYMPHOCYTIC DISORDERS |